1. A. Karim, C. Cook, R. L. Novotney, J. Zagarella, and J. Campion. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.Drug Metab Dispos. 6:338–345 (1978).
2. A. Karim, R. E. Ranney, and S. Kraychy. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate.J. Pharm. Sci. 61:888–893 (1972).
3. R. E. Ranney, R. R. Dean, A. Karim, and F. M. Radzialowski. Disopyramide phosphate: pharmacokinetics and pharmacologic relationships of a new antiarrhythmic agent.Arch. Int. Phamacodyn. 191:162–188 (1971).
4. A. Karim. The pharmacokinetics of Norpace.Angiology 264 (Suppl. 2, part 1): 85–98 (1975).
5. W. S. Hillis, A. Tweddel, A. R. Lorimer, and T. D. V. Lawrie. Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction.J. Intern. Med. Res. 4 (Suppl. 1):74–77 (1976).